United States Oral Solid Dosage Pharmaceutical Formulation Market Report 2017

December 2017 | 113 pages | ID: UDC89844506EN
QYResearch

Abstracts

In this report, the United States Oral Solid Dosage Pharmaceutical Formulation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Oral Solid Dosage Pharmaceutical Formulation in these regions, from 2012 to 2022 (forecast).

United States Oral Solid Dosage Pharmaceutical Formulation market competition by top manufacturers/players, with Oral Solid Dosage Pharmaceutical Formulation sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca Plc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Gilead Sciences
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• AbbVie Inc.
• Boehringer Ingelheim GmbH
• Hoffman-La-Roche Ltd.
• Johnson & Johnson
• Biogen Inc.
• Bayer AG
• Teva Pharmaceticals
• Amgen Inc.
• Takeda Pharmaceutical Company Ltd.
• Otsuka Pharmaceutical Co., Ltd.
• Shire Plc.
• Celgene Corporation
• Astellas Pharma Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Form
• Capsules
• Powders
• Tablets
• By Drug Release Mechanism
• Immediate Release
• Extended Release

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Oral Solid Dosage Pharmaceutical Formulation Market Report 2017

1 ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION OVERVIEW

1.1 Product Overview and Scope of Oral Solid Dosage Pharmaceutical Formulation
1.2 Classification of Oral Solid Dosage Pharmaceutical Formulation by Product Category
  1.2.1 United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Capsules
  1.2.4 Powders
  1.2.5 Tablets
1.3 United States Oral Solid Dosage Pharmaceutical Formulation Market by Application/End Users
  1.3.1 United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Other
1.4 United States Oral Solid Dosage Pharmaceutical Formulation Market by Region
  1.4.1 United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
  1.4.3 Southwest Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
  1.4.5 New England Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
  1.4.6 The South Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
  1.4.7 The Midwest Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oral Solid Dosage Pharmaceutical Formulation (2012-2022)
  1.5.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2022)
  1.5.2 United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2022)

2 UNITED STATES ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oral Solid Dosage Pharmaceutical Formulation Average Price by Players/Suppliers (2012-2017)
2.4 United States Oral Solid Dosage Pharmaceutical Formulation Market Competitive Situation and Trends
  2.4.1 United States Oral Solid Dosage Pharmaceutical Formulation Market Concentration Rate
  2.4.2 United States Oral Solid Dosage Pharmaceutical Formulation Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Solid Dosage Pharmaceutical Formulation Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Region (2012-2017)
3.2 United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Region (2012-2017)
3.3 United States Oral Solid Dosage Pharmaceutical Formulation Price by Region (2012-2017)

4 UNITED STATES ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Solid Dosage Pharmaceutical Formulation Price by Type (2012-2017)
4.4 United States Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Application (2012-2017)
5.2 United States Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca Plc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
  6.2.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly and Company
  6.3.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Gilead Sciences
  6.4.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck & Co. Inc.
  6.5.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis AG
  6.6.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pfizer Inc.
  6.7.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 AbbVie Inc.
  6.8.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Boehringer Ingelheim GmbH
  6.9.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Hoffman-La-Roche Ltd.
  6.10.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Biogen Inc.
6.13 Bayer AG
6.14 Teva Pharmaceticals
6.15 Amgen Inc.
6.16 Takeda Pharmaceutical Company Ltd.
6.17 Otsuka Pharmaceutical Co., Ltd.
6.18 Shire Plc.
6.19 Celgene Corporation
6.20 Astellas Pharma Inc.

7 ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MANUFACTURING COST ANALYSIS

7.1 Oral Solid Dosage Pharmaceutical Formulation Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Forecast by Type (2017-2022)
11.3 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Forecast by Application (2017-2022)
11.4 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oral Solid Dosage Pharmaceutical Formulation
Figure United States Oral Solid Dosage Pharmaceutical Formulation Market Size (K MT) by Type (2012-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsules Product Picture
Figure Powders Product Picture
Figure Tablets Product Picture
Figure United States Oral Solid Dosage Pharmaceutical Formulation Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) by Region (2012-2022)
Figure The West Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players/Suppliers
Figure 2017 United States Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players/Suppliers
Figure United States Oral Solid Dosage Pharmaceutical Formulation Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players/Suppliers
Figure 2017 United States Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players/Suppliers
Table United States Market Oral Solid Dosage Pharmaceutical Formulation Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Oral Solid Dosage Pharmaceutical Formulation Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Oral Solid Dosage Pharmaceutical Formulation Market Share of Top 3 Players/Suppliers
Figure United States Oral Solid Dosage Pharmaceutical Formulation Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Solid Dosage Pharmaceutical Formulation Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Solid Dosage Pharmaceutical Formulation Product Category
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Region (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Share by Region (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Share by Region (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Region in 2016
Table United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Region (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region in 2016
Table United States Oral Solid Dosage Pharmaceutical Formulation Price (USD/MT) by Region (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Type (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Share by Type (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Share by Type (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type in 2016
Table United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type (2012-2017)
Figure Revenue Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type in 2016
Table United States Oral Solid Dosage Pharmaceutical Formulation Price (USD/MT) by Types (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Type (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Application (2012-2017)
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application in 2016
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Application (2012-2017)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Plc. Basic Information List
Table AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table Merck & Co. Inc. Basic Information List
Table Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table AbbVie Inc. Basic Information List
Table AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table Hoffman-La-Roche Ltd. Basic Information List
Table Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)
Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in United States (2012-2017)
Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Biogen Inc. Basic Information List
Table Bayer AG Basic Information List
Table Teva Pharmaceticals Basic Information List
Table Amgen Inc. Basic Information List
Table Takeda Pharmaceutical Company Ltd. Basic Information List
Table Otsuka Pharmaceutical Co., Ltd. Basic Information List
Table Shire Plc. Basic Information List
Table Celgene Corporation Basic Information List
Table Astellas Pharma Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Solid Dosage Pharmaceutical Formulation
Figure Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation
Figure Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis
Table Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Players/Suppliers in 2016
Table Major Buyers of Oral Solid Dosage Pharmaceutical Formulation
Table Distributors/Traders List
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Price (USD/MT) Trend Forecast (2017-2022)
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) Forecast by Type in 2022
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) Forecast by Application in 2022
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources